We are delighted that @nicecomms has approved the groundbreaking gene therapy CASGEVY® (Exa-cel) for use in the NHS for people living with Sickle Cell Disease.
More here: nice.org.uk/news/article...

#SickleCell #BlackHealthMatters #GeneTherapy #HealthEquity